Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters-Reference-Cited by-同舟云学术

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

Published:2015-08-25 Issue:12 Volume:4 Page:813-821
ISSN:2322-5939
Container-title:International Journal of Health Policy and Management
language:en
Short-container-title:Int J Health Policy Manag

Author:

Kim Hyosun

Publisher

Maad Rayan Publishing Company

Subject

Health Policy,Health Information Management,Leadership and Management,Management, Monitoring, Policy and Law,Health(social science)

Link

http://ijhpm.com/article_3083_c5885a53cd19640e9d9aa3171a12269f.pdf

Reference37 articles.

1. Campbell S. Promotional Spending for Prescription Drugs. https://www.cbo.gov/sites/default/files/111th-congress-2009-2010/reports/12-02-drugpromo_brief.pdf. Accessed April 16, 2015. Published December 2, 2009.

2. The development of direct-to-consumer prescription drug advertising regulation;Palumbo FB;Food Drug Law J,2002

3. Public policy issues in direct-to-consumer advertising of prescription drugs;Calfee J;J Public Policy Mark,2002

4. Campbell S. Potential Effects of a Ban on Direct-to-Consumer Advertising of New Prescription Drugs. https://www.cbo.gov/sites/default/files/112th-congress-2011-2012/reports/5-25-prescriptiondrugadvertising.pdf. Published May 2011.

5. Dobrow L. DTC Report: DTC Gets Smart - Medical Marketing and Media. Med Mark Media. http://www.mmm-online.com/features/dtc-report-dtc-gets-smart/article/339357/. Accessed August 22, 2015. Published 2014.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study;Journal of Medical Internet Research;2023-07-17

2. When consumers lose power: An examination of the stakeholder dynamics in the pharmaceutical industry;Business Ethics, the Environment & Responsibility;2023-04-26

3. Online but unlawful sales of unapproved and misbranded prescription drugs: Internet pharmacy compliance with Food and Drug Administration warning letters;Journal of Consumer Affairs;2023-02-28

4. Digital brand transformers and digital engagement in Indian pharmaceutical industry during COVID 19;INTERNATIONAL CONFERENCE ON RESEARCH INNOVATIONS: TRENDS IN SCIENCE AND TECHNOLOGY;2023

5. Character-space-limited online prescription drug communications: Four experimental studies;Research in Social and Administrative Pharmacy;2022-12